Loading organizations...
§ Venture Capital · New York City, NY, USA
Dedicated healthcare venture capital firm investing in life sciences, focused on therapeutics and medical devices.
Amzak Health Investors is a venture capital and growth equity firm focused on the broader life sciences sector, operating out of headquarters in New York and Boca Raton, Florida. Operating as the dedicated healthcare investment arm of the Kazma family office, known as Amzak Capital Management, the firm's principals have invested in over 50 private and public healthcare companies since 2005. The firm primarily allocates capital toward biotechnology, biopharmaceutical, and medical device enterprises that are actively developing novel therapeutics, advanced diagnostics, and specialized healthcare services. Its daily investment activities are managed by an independent entity called Majalin LLC, and the firm's historical portfolio includes notable life sciences companies such as Cara Therapeutics, Aura Biosciences, and Vapotherm. Amzak Health Investors was officially founded in 2015 by managing partner Joyce Erony and members of the Kazma family.
Key people at Amzak Health Investors.
Amzak Health Investors is a venture capital firm specializing in investing in first-in-class and best-in-class technologies within the medtech and biotech sectors. Their mission centers on improving patient care by backing innovative life science companies that address unmet medical needs. Operating as an evergreen fund, Amzak Health invests in both private and select public companies, partnering closely with management teams to support growth and success. Their portfolio includes companies developing advanced medical technologies such as non-invasive tumor ablation and women's health devices, highlighting their focus on transformative healthcare innovations[1][2][3][5].
Founded with a focus on life sciences, Amzak Health's team brings extensive investing and operating experience in biotech and medtech. While specific founding year details are not publicly emphasized, the firm is led by key partners including Managing Partner Joyce Erony and Principal Dave Siet. The firm has evolved to support early to growth-stage companies across North America and Europe, leveraging deep industry expertise to foster innovation and commercial success. Their investment approach is collaborative, working as partners rather than just capital providers[1][2][3].
Amzak Health rides the wave of rapid innovation in life sciences, particularly in medtech and biotech, where breakthroughs in diagnostics, therapeutics, and medical devices are reshaping healthcare. The timing is critical as healthcare systems worldwide demand more effective, less invasive, and cost-efficient solutions. Market forces such as aging populations, rising chronic diseases, and technological advances in imaging and energy-based therapies favor Amzak’s investment focus. By backing pioneering companies, Amzak Health influences the ecosystem by accelerating the commercialization of novel medical technologies that improve patient outcomes[1][2][5].
Looking ahead, Amzak Health is poised to continue expanding its portfolio in cutting-edge healthcare innovations, likely increasing investments in areas like non-invasive therapies, precision medicine, and digital health integration. Trends such as AI-driven diagnostics and personalized treatments will shape their journey, enhancing their influence in transforming healthcare delivery. Their partnership-driven model and evergreen fund structure position them well to support companies through long development cycles and regulatory pathways, sustaining their role as a key enabler of life science innovation[1][2][3][5].
Key people at Amzak Health Investors.
